Key result
Alveolar soft-part sarcoma was associated with actuarial survival rates of 82.8% at two years, 59% at five years, and 47.1% at ten years.
Observational (n=53)
Alveolar soft-part sarcoma is a slow-growing tumor with a 10-year survival rate of approximately 47%, predominantly affecting females at an earlier age than males.
May refine prognostic counseling in alveolar soft-part sarcoma; leaves open optimal therapy pending higher-level evidence.
Fifty-three cases of alveolar soft-part sarcoma were analyzed. Forty-six cases were followed long enough to permit collection of survival data by actuarial methods: 82.8% (±5.9%) in two years, 59% (±8.8%) in five years, and 47.1% (±9.3%) in ten years. Most tumors were noted in female patients and there seemed to be a trend toward right-sided laterality. Tumors developed in female patients at an earlier age than in male patients. The histogenesis of the tumor remains uncertain. The paucity of information and the sluggishness of tumor growth make interpretation of therapeutic effects difficult.
No takes yet. Share an insight, caveat, or question.
Philip Lieberman (1966) conducted an observational in Alveolar soft-part sarcoma (n=53). Alveolar soft-part sarcoma was evaluated on 10-year survival. Alveolar soft-part sarcoma was associated with actuarial survival rates of 82.8% at two years, 59% at five years, and 47.1% at ten years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: